Informationsmanagement verbessert signifikant die glykämische Stoffwechseleinstellung bei Typ-2-Diabetes: Ergebnisse der multizentrischen, nicht-interventionellen VISION Studie

Weissmann, John S.; Mueller, A. J.; Pralle, K.; Ruessmann, H; Gregersen, B; Messinger, Diethelm; Amann-Zalán, Ildikó

doi:10.1055/s-0032-1314609

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another study, the Vision Study, investigators showed that graphic display of self-monitored blood glucose data significantly improved metabolic control, with an impressive 0.93% reduction in HbA1c in the type 2 diabetes patients studied. 17 Seeing is believing for many patients. 10.…”

Section: The 10 Commandmentsmentioning

confidence: 99%

There Is a Missing Ingredient in Diabetes Care Today

Alzaid

2014

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

Section: The 10 Commandmentsmentioning

confidence: 99%

There Is a Missing Ingredient in Diabetes Care Today

Alzaid

2014

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

“…34 This study examined the effects of displaying SMBG information graphically using the Accu-Chek SmartPix system on glycemic control and physician-patient dialog. The study was a prospective, 6-month, multicenter, observational study that included people with type 1 and type 2 diabetes attending 129 practices in Germany.…”

Section: Alzaid Et Almentioning

confidence: 99%

6^thAnnual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, April 25–27, 2013, Riga, Latvia

Alzaid

Schlaeger²,

Hinzmann³

2013

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

International experts in the fields of diabetes, diabetes technology, endocrinology, and pediatrics gathered for the 6 th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and beyond. The aim of this meeting was to continue setting up a global network of experts in this field and provide an international platform for exchange of ideas to improve life for people with diabetes. The 2013 meeting comprised a comprehensive scientific program, parallel interactive workshops, and two keynote lectures. All these discussions were intended to help identify gaps and areas where further scientific work and clinical studies are warranted. Opening Lecture: News from the World of DiabetesSatish Garg, University of Colorado Denver, Aurora, Colorado Drugs can't do it alone, we need technology too S atish Garg, in his opening lecture, gave insights into the status of diabetes care in general, described the direction of the ongoing diabetes research, and unveiled exciting technological advances coming our way in the near future. He argued that diabetes technology has a major contribution to make on the quality of life and the day-to-day interaction between patient and disease. He put forward a poignant question, saying that we are almost spoiled for choice by the number of antidiabetes agents currently available to treat diabetes, but has that changed patient outcome?Garg advocated that drugs cannot do it alone and that there is a clear gap in the management of diabetes that may be filled in by diabetes-related technologies. Diabetes: uncontrollable costGarg presented recently published data that show the cost of diabetes alone amounts to a staggering $245 billion per year in the United States.1 This figure is expected to rise in the future. Almost one-third of people with diabetes belong to the elderly age group (above 65 years of age), meaning that most individuals have been systematically excluded from research trials and clinical studies. Garg made a timely and passionate plea that elderly people with diabetes must not be left out of the diabetes research agenda.A closer examination of the cost of diabetes expenditure reveals that 80% of the money is used to pay for services and late complications. Eight percent of the total expenditure is used for diabetes technology. Garg suggested that people with diabetes should be cared for from the outset to reduce the expense incurred due to late complications. Glycated hemoglobin and hypoglycemia as measures of healthcare outcomeRecent clinical data of 25,000 people with type 1 diabetes attending 67 leading diabetes centers across the United States were presented by Garg. The T1D Exchange Study 2 is an observational study that showed several interesting findings. First, despite all existing efforts, the pursuit of the target glycated hemoglobin (HbA1c) level remains elusive for many people with diabetes across the United States. Second, the incidence of hypoglycemia remains a major concern for many people with diabetes, especially the elderly. Another and...

show abstract

Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program

Lange

Ziegler²,

Neu

et al. 2015

Current Medical Research and Opinion

View full text Add to dashboard Cite

Use of continuous subcutaneous insulin infusion (CSII) therapy improves glycemic control, reduces hypoglycemia and increases treatment satisfaction in individuals with diabetes. As a number of patient- and clinician-related factors can hinder the effectiveness and optimal usage of CSII therapy, new approaches are needed to address these obstacles. Ceriello and colleagues recently proposed a model of care that incorporates the collaborative use of structured SMBG into a formal approach to personalized diabetes management within all diabetes populations. We adapted this model for use in CSII-treated patients in order to enable the implementation of a workflow structure that enhances patient-physician communication and supports patients' diabetes self-management skills. We recognize that time constraints and current reimbursement policies pose significant challenges to healthcare providers integrating the Personalised Diabetes Management (PDM) process into clinical practice. We believe, however, that the time invested in modifying practice workflow and learning to apply the various steps of the PDM process will be offset by improved workflow and more effective patient consultations. This article describes how to implement PDM into clinical practice as a systematic, standardized process that can optimize CSII therapy.

show abstract

Informationsmanagement verbessert signifikant die glykämische Stoffwechseleinstellung bei Typ-2-Diabetes: Ergebnisse der multizentrischen, nicht-interventionellen VISION Studie

Cited by 3 publications

References 0 publications

There Is a Missing Ingredient in Diabetes Care Today

There Is a Missing Ingredient in Diabetes Care Today

6^thAnnual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, April 25–27, 2013, Riga, Latvia

Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program

Contact Info

Product

Resources

About

Informationsmanagement verbessert signifikant die glykämische Stoffwechseleinstellung bei Typ-2-Diabetes: Ergebnisse der multizentrischen, nicht-interventionellen VISION Studie

Cited by 3 publications

References 0 publications

There Is a Missing Ingredient in Diabetes Care Today

There Is a Missing Ingredient in Diabetes Care Today

6thAnnual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, April 25–27, 2013, Riga, Latvia

Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program

Contact Info

Product

Resources

About

6^thAnnual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, April 25–27, 2013, Riga, Latvia